2 Xideas Ag Edwards Lifesciences Corp Transaction History

2 Xideas Ag

$614 Million
Q1 2025

A detailed history of 2 Xideas Ag transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, 2 Xideas Ag holds 190,584 shares of EW stock, worth $14.4 Million. This represents 2.25% of its overall portfolio holdings.

Number of Shares

190,584

Previous 177,296 7.49%

Holding current value

$14.4 Million

Previous $13.1 Million 5.24%

% of portfolio

2.25%

Previous 1.93%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$67.95 - $76.19 $902,919 - $1.01 Million	13,288 Added 7.49%	190,584 $13.8 Million
Q4 2024 Feb 13, 2025	SELL	$64.54 - $75.92 $3.02 Million - $3.55 Million	-46,786 Reduced 20.88%	177,296 $13.1 Million
Q3 2024 Nov 13, 2024	BUY	$59.7 - $93.78 $1.28 Million - $2.01 Million	21,404 Added 10.56%	224,082 $14.8 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $520,131 - $581,892	6,170 Added 3.14%	202,678 $18.7 Million
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $2.94 Million - $3.87 Million	40,465 Added 25.93%	196,508 $18.8 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $1.15 Million - $1.45 Million	18,652 Added 13.58%	156,043 $11.9 Million
Q3 2023 Nov 07, 2023	SELL	$69.28 - $93.38 $246,082 - $331,685	-3,552 Reduced 2.52%	137,391 $9.52 Million
Q2 2023 Aug 10, 2023	SELL	$81.41 - $94.33 $73,106 - $84,708	-898 Reduced 0.63%	140,943 $13.3 Million
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $805,498 - $916,679	10,847 Added 8.28%	141,841 $11.7 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $1.79 Million - $2.29 Million	26,203 Added 25.01%	130,994 $9.77 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $748,249 - $974,622	-9,084 Reduced 7.98%	104,791 $8.66 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $821,058 - $1.22 Million	-9,492 Reduced 7.69%	113,875 $10.8 Million
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $501,133 - $630,791	-4,915 Reduced 3.83%	123,367 $14.5 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $2.25 Million - $2.76 Million	21,148 Added 19.74%	128,282 $16.6 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $280,944 - $335,107	-2,730 Reduced 2.48%	107,134 $12.1 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $1.07 Million - $1.33 Million	12,741 Added 13.12%	109,864 $11.4 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $1.34 Million - $1.54 Million	17,007 Added 21.23%	97,123 $8.12 Million
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $5.74 Million - $7.31 Million	80,116 New	80,116 $7.31 Million

Others Institutions Holding EW

# of Institutions

1,376

Shares Held

486M

Call Options Held

2.77M

Put Options Held

2.05M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of 2 Xideas Ag, based on Form 13F filings with the SEC.

News

Stay updated on 2 Xideas Ag with notifications on news.

Account